**Core Concept**
The C-MYC oncogene plays a crucial role in cellular proliferation and differentiation. Amplification of the C-MYC gene can lead to overexpression of the MYC protein, which in turn promotes uncontrolled cell growth and tumor formation. This process is a common mechanism underlying various types of cancer, including colonic malignancy.

**Why the Correct Answer is Right**
Amplification of the C-MYC gene results in an increased number of copies of the gene, leading to overexpression of the MYC protein. This overexpression disrupts normal cell cycle regulation, allowing cells to proliferate uncontrollably and contributing to tumorigenesis. In colonic malignancy, C-MYC amplification is often associated with poor prognosis and aggressive disease behavior.

**Why Each Wrong Option is Incorrect**
**Option A:** Point mutations in the C-MYC gene can disrupt its function, but they are not typically associated with oncogenic transformation. Point mutations can lead to loss-of-function or dominant-negative effects, which are not conducive to tumorigenesis.
**Option C:** Rearrangement of the C-MYC gene, such as translocation, is more commonly associated with B-cell malignancies, such as Burkitt lymphoma. While rearrangements can activate oncogenes, they are not the primary mechanism underlying C-MYC-driven colonic malignancy.
**Option D:** Deletion of the C-MYC gene would be expected to result in loss of function, which is not conducive to tumorigenesis. In fact, loss of C-MYC function has been associated with tumor suppression and improved prognosis in some contexts.

**Clinical Pearl / High-Yield Fact**
Amplification of the C-MYC gene is a common feature of many types of cancer, including breast, lung, and colon cancer. In the context of colonic malignancy, C-MYC amplification is often associated with a poor prognosis and aggressive disease behavior.

**✓ Correct Answer: B. Amplification**